{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:23:56Z","timestamp":1761895436508},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1590\/s1677-55382011000600004","type":"journal-article","created":{"date-parts":[[2012,2,4]],"date-time":"2012-02-04T09:12:47Z","timestamp":1328346767000},"page":"706-711","source":"Crossref","is-referenced-by-count":3,"title":["Patients with a negative cystoscopy and negative Nmp22\u00ae Bladderchek\u00ae test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation"],"prefix":"10.1590","volume":"37","author":[{"given":"John D.","family":"Terrell","sequence":"first","affiliation":[{"name":"University of Texas Southwestern Medical Center,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren J.","family":"Elias","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur I.","family":"Sagalowsky","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal A","year":"2010","journal-title":"CA Cancer J Clin."},{"key":"ref2","series-title":"Surveillance Edpidemiology and End Results: providing information on cancer statistics to help reduce the burden of this disease on the U.S. population","year":"2011"},{"key":"ref3","series-title":"National Cancer Data Base","year":"2011"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.22084","article-title":"Should we screen for bladder cancer in a high-risk population: A cost per life-year saved analysis","volume":"107","author":"Lotan Y","year":"2006","journal-title":"Cancer."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/01.ju.0000181814.73466.14","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko DI","year":"2005","journal-title":"J Urol."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.urology.2006.12.023","article-title":"Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","volume":"69","author":"Denzinger S","year":"2007","journal-title":"Urology."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0302-2838(03)00147-7","article-title":"How important is urinary cytology in the diagnosis of urological malignancies?","volume":"43","author":"Nabi G","year":"2003","journal-title":"Eur Urol."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000019851","article-title":"Reliability of the routine cytological diagnosis in bladder cancer","volume":"35","author":"P\u00e1ez A","year":"1999","journal-title":"Eur Urol."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan Y","year":"2003","journal-title":"Urology."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jama.293.7.810","article-title":"Detection of bladder cancer using a point-of-care proteomic assay","volume":"293","author":"Grossman HB","year":"2005","journal-title":"JAMA."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.295.3.299","article-title":"Surveillance for recurrent bladder cancer using a point-of-care proteomic assay","volume":"295","author":"Grossman HB","year":"2006","journal-title":"JAMA."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling KC","year":"2000","journal-title":"J Urol."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000273465","article-title":"Urine cytology in the evaluation of urological malignancy revisited: is it still necessary?","volume":"84","author":"Falebita OA","year":"2010","journal-title":"Urol Int."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.urology.2009.09.091","article-title":"Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients","volume":"75","author":"Feifer AH","year":"2010","journal-title":"Urology."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.juro.2009.08.157","article-title":"Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder","volume":"183","author":"Schlomer BJ","year":"2010","journal-title":"J Urol."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-5347(05)65386-4","article-title":"Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach","volume":"167","author":"Lotan Y","year":"2002","journal-title":"J Urol."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman MF","year":"2003","journal-title":"Pharmacoeconomics."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0090-4295(00)00489-1","article-title":"Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors","volume":"55","author":"Giannopoulos A","year":"2000","journal-title":"Urology."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/ADJL7E810U1H42BJ","article-title":"Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings","volume":"127","author":"Yoder BJ","year":"2007","journal-title":"Am J Clin Pathol."}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v37n6\/a04v37n6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T04:23:13Z","timestamp":1495858993000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382011000600004&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1677-55382011000600004"],"URL":"https:\/\/doi.org\/10.1590\/s1677-55382011000600004","relation":{},"ISSN":["1677-5538"],"issn-type":[{"value":"1677-5538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}